Analyst Briefings : Strategic Analysis & Forecast of US Biopharmaceutical Industry (2009-2016)
The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs
View full press release